Prethermalization and thermalization in models with weak integrability breaking B Bertini, FHL Essler, S Groha, NJ Robinson Physical review letters 115 (18), 180601, 2015 | 230 | 2015 |
Thermalization and light cones in a model with weak integrability breaking B Bertini, FHL Essler, S Groha, NJ Robinson Physical Review B 94 (24), 245117, 2016 | 88 | 2016 |
HLA-A* 03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study V Naranbhai, M Viard, M Dean, S Groha, DA Braun, C Labaki, SA Shukla, ... The Lancet Oncology 23 (1), 172-184, 2022 | 84 | 2022 |
Full counting statistics in the transverse field Ising chain S Groha, F Essler, P Calabrese SciPost Physics 4 (6), 043, 2018 | 76 | 2018 |
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors AH Nassar, E Adib, S Abou Alaiwi, T El Zarif, S Groha, EW Akl, PV Nuzzo, ... Cancer Cell 40 (10), 1161-1172. e5, 2022 | 72 | 2022 |
Germline variants associated with toxicity to immune checkpoint blockade S Groha, SA Alaiwi, W Xu, V Naranbhai, AH Nassar, Z Bakouny, T El Zarif, ... Nature medicine 28 (12), 2584-2591, 2022 | 62 | 2022 |
Immunotherapy-mediated thyroid dysfunction: genetic risk and impact on outcomes with PD-1 blockade in non–small cell lung cancer J Luo, VL Martucci, Z Quandt, S Groha, MH Murray, CM Lovly, H Rizvi, ... Clinical Cancer Research 27 (18), 5131-5140, 2021 | 57 | 2021 |
Variation in targetable genomic alterations in non-small cell lung cancer by genetic ancestry, sex, smoking history, and histology E Adib, AH Nassar, S Abou Alaiwi, S Groha, EW Akl, LM Sholl, ... Genome Medicine 14 (1), 39, 2022 | 51 | 2022 |
Full counting statistics in the spin-1/2 Heisenberg XXZ chain M Collura, FHL Essler, S Groha Journal of Physics A: Mathematical and Theoretical 50 (41), 414002, 2017 | 44 | 2017 |
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma CA Taylor, RA Watson, O Tong, W Ye, I Nassiri, JJ Gilchrist, ... Nature Medicine 28 (12), 2592-2600, 2022 | 38 | 2022 |
Constructing germline research cohorts from the discarded reads of clinical tumor sequences A Gusev, S Groha, K Taraszka, YR Semenov, N Zaitlen Genome medicine 13, 1-14, 2021 | 37 | 2021 |
Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation SC Baca, C Singler, S Zacharia, JH Seo, T Morova, F Hach, Y Ding, ... Nature genetics 54 (9), 1364-1375, 2022 | 31 | 2022 |
A general framework for survival analysis and multi-state modelling S Groha, SM Schmon, A Gusev arXiv preprint arXiv:2006.04893, 2020 | 26* | 2020 |
Trans-ethnic variation in germline variants of patients with renal cell carcinoma S Abou Alaiwi, AH Nassar, E Adib, SM Groha, EW Akl, BA McGregor, ... Cell reports 34 (13), 2021 | 18 | 2021 |
Clinical inflection point detection on the basis of EHR data to identify clinical trial–ready patients with cancer KL Kehl, S Groha, EM Lepisto, H Elmarakeby, J Lindsay, A Gusev, ... JCO Clinical Cancer Informatics 5, 622-630, 2021 | 14 | 2021 |
SurvLatent ODE: A Neural ODE based time-to-event model with competing risks for longitudinal data improves cancer-associated Venous Thromboembolism (VTE) prediction I Moon, S Groha, A Gusev Machine Learning for Healthcare Conference, 800-827, 2022 | 12 | 2022 |
Spinon decay in the spin-1/2 Heisenberg chain with weak next nearest neighbour exchange S Groha, FHL Essler Journal of Physics A: Mathematical and Theoretical 50 (33), 334002, 2017 | 10 | 2017 |
Genetic variation at IL7 provides mechanistic insights into toxicity to immune checkpoint blockade B Fairfax, C Taylor, R Watson, O Tong, W Ye, I Nassiri, J Gilchrist, ... | 2 | 2022 |
Seeing beyond the target: leveraging off-target reads in targeted clinical tumor sequencing to identify prognostic biomarkers S Mangul, JJ Brito, S Groha, N Zaitlen, A Gusev bioRxiv, 2021.05. 28.446240, 2021 | 2 | 2021 |
Elucidating analytic bias due to informative cohort entry in cancer clinico-genomic datasets KL Kehl, H Uno, A Gusev, S Groha, S Brown, JA Lavery, D Schrag, ... Cancer Epidemiology, Biomarkers & Prevention 32 (3), 344-352, 2023 | 1 | 2023 |